Neuroscience and Biobehavioral Reviews Cellular and Molecular Neuropathology of the Cuprizone Mouse Model: Clinical Relevance for Multiple Sclerosis

[1]  S. Ovsepian,et al.  Disruption of Myelin Leads to Ectopic Expression of KV1.1 Channels with Abnormal Conductivity of Optic Nerve Axons in a Cuprizone-Induced Model of Demyelination , 2014, PloS one.

[2]  G. Rabinovich,et al.  Galectin-3 controls the response of microglial cells to limit cuprizone-induced demyelination , 2014, Neurobiology of Disease.

[3]  D. Ron,et al.  PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases. , 2014, The American journal of pathology.

[4]  Frederik Maes,et al.  Multimodal imaging of subventricular zone neural stem/progenitor cells in the cuprizone mouse model reveals increased neurogenic potential for the olfactory bulb pathway, but no contribution to remyelination of the corpus callosum , 2014, NeuroImage.

[5]  Hong-Ju Yang,et al.  Differential effects of antipsychotics on the development of rat oligodendrocyte precursor cells exposed to cuprizone , 2014, European Archives of Psychiatry and Clinical Neuroscience.

[6]  A. Sawa,et al.  Cuprizone short-term exposure: Astrocytic IL-6 activation and behavioral changes relevant to psychosis , 2013, Neurobiology of Disease.

[7]  F. Gage,et al.  A regenerative approach to the treatment of multiple sclerosis , 2013, Nature.

[8]  V. Gallo,et al.  SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis , 2013, Glia.

[9]  Tatsuhide Tanaka,et al.  Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone‐induced demyelination , 2013, Journal of neurochemistry.

[10]  Elena V. Klassen,et al.  Puma, but not noxa is essential for oligodendroglial cell death , 2013, Glia.

[11]  G. Hassanzadeh,et al.  Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain. , 2013, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[12]  H. Basoglu,et al.  Cuprizone-induced demyelination in Wistar rats; electrophysiological and histological assessment. , 2013, European review for medical and pharmacological sciences.

[13]  M. Selak,et al.  Distribution of oligodendrocyte loss and mitochondrial toxicity in the cuprizone-induced experimental demyelination model , 2013, Journal of Neuroimmunology.

[14]  R. Armstrong,et al.  FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination , 2013, Neuroscience Letters.

[15]  Short-Term Cuprizone Feeding Induces Selective Amino Acid Deprivation with Concomitant Activation of an Integrated Stress Response in Oligodendrocytes , 2013, Cellular and Molecular Neurobiology.

[16]  S. Moore,et al.  Sex chromosome complement influences functional callosal myelination , 2013, Neuroscience.

[17]  K. Kleopa,et al.  Alterations of juxtaparanodal domains in two rodent models of CNS demyelination , 2013, Glia.

[18]  C. Rapôso,et al.  Sildenafil (Viagra) Protective Effects on Neuroinflammation: The Role of iNOS/NO System in an Inflammatory Demyelination Model , 2013, Mediators of inflammation.

[19]  Rhusheet P Patel,et al.  Attenuation of Corpus Callosum Axon Myelination and Remyelination in the Absence of Circulating Sex Hormones , 2013, Brain pathology.

[20]  J. Maeda,et al.  Loss of Branched O-Mannosyl Glycans in Astrocytes Accelerates Remyelination , 2013, The Journal of Neuroscience.

[21]  V. Baekelandt,et al.  Local Overexpression of Interleukin-11 in the Central Nervous System Limits Demyelination and Enhances Remyelination , 2013, Mediators of inflammation.

[22]  TRO19622 promotes myelin repair in a rat model of demyelination , 2013, The International journal of neuroscience.

[23]  Cuprizone-Induced Demyelination as a Tool to Study Remyelination and Axonal Protection , 2013, Journal of Molecular Neuroscience.

[24]  Cheng He,et al.  A functional role of NMDA receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination , 2013, Glia.

[25]  T. Kilpatrick,et al.  Investigation of Sequential Growth Factor Delivery during Cuprizone Challenge in Mice Aimed to Enhance Oligodendrogliogenesis and Myelin Repair , 2013, PloS one.

[26]  B. Trapp,et al.  Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR‐124 and reduced AMPA receptors , 2013, Annals of neurology.

[27]  Chengren Li,et al.  Cuprizone-induced demyelination in mice: age-related vulnerability and exploratory behavior deficit , 2013, Neuroscience Bulletin.

[28]  G. Matsushima,et al.  Abbreviated exposure to cuprizone is sufficient to induce demyelination and oligodendrocyte loss , 2013, Journal of neuroscience research.

[29]  J. Boggs,et al.  G protein‐coupled receptor 30 contributes to improved remyelination after cuprizone‐induced demyelination , 2013, Glia.

[30]  Vikramjeet Singh,et al.  Cuprizone [Bis(Cyclohexylidenehydrazide)] is Selectively Toxic for Mature Oligodendrocytes , 2013, Neurotoxicity Research.

[31]  Yan Xu,et al.  Progesterone Alleviates Neural Behavioral Deficits and Demyelination with Reduced Degeneration of Oligodendroglial Cells in Cuprizone-Induced Mice , 2013, PloS one.

[32]  W. Baumgärtner,et al.  Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. , 2013, Brain : a journal of neurology.

[33]  Bartosz Bielecki,et al.  The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination. , 2013, Brain : a journal of neurology.

[34]  R. Armstrong,et al.  Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination , 2012, ASN neuro.

[35]  A. Chédotal,et al.  Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination , 2012, Glia.

[36]  D. Pleasure,et al.  Interferon regulatory factor 8/interferon consensus sequence binding protein is a critical transcription factor for the physiological phenotype of microglia , 2012, Journal of Neuroinflammation.

[37]  L. P. Chen,et al.  Regulation of Olig2 during astroglial differentiation in the subventricular zone of a cuprizone-induced demyelination mouse model , 2012, Neuroscience.

[38]  R. Klein,et al.  Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS , 2012, Acta Neuropathologica.

[39]  S. Komoly,et al.  Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination. , 2012, Ideggyogyaszati szemle.

[40]  P. Paez,et al.  Golli myelin basic proteins stimulate oligodendrocyte progenitor cell proliferation and differentiation in remyelinating adult mouse brain , 2012, Glia.

[41]  R. Ransohoff,et al.  IL-17-Induced Act1-Mediated Signaling Is Critical for Cuprizone-Induced Demyelination , 2012, The Journal of Neuroscience.

[42]  J. Frahm,et al.  Erythropoietin Attenuates Neurological and Histological Consequences of Toxic Demyelination in Mice , 2012, Molecular Medicine.

[43]  J. Pasquini,et al.  Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination , 2012, Experimental Neurology.

[44]  B. Barres,et al.  The T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration , 2012, Molecular and Cellular Neuroscience.

[45]  F. Bosetti,et al.  The cyclooxygenase‐2 pathway via the PGE2 EP2 receptor contributes to oligodendrocytes apoptosis in cuprizone‐induced demyelination , 2012, Journal of neurochemistry.

[46]  Ralph Sinkus,et al.  Demyelination reduces brain parenchymal stiffness quantified in vivo by magnetic resonance elastography , 2012, Proceedings of the National Academy of Sciences.

[47]  J. Kong,et al.  Galanin Transgenic Mice with Elevated Circulating Galanin Levels Alleviate Demyelination in a Cuprizone-Induced MS Mouse Model , 2012, PloS one.

[48]  R. König,et al.  Expression of retinoid X receptor beta is induced in astrocytes during corpus callosum demyelination , 2012, Journal of Chemical Neuroanatomy.

[49]  S. Mori,et al.  In vivo and ex vivo diffusion tensor imaging of cuprizone‐induced demyelination in the mouse corpus callosum , 2012, Magnetic resonance in medicine.

[50]  D. Mahad,et al.  Mitochondrial changes associated with demyelination: consequences for axonal integrity. , 2012, Mitochondrion.

[51]  N. Yamada,et al.  Hexachlorophene and cuprizone induce the spongy change of the developing rat brain by different mechanisms: the role of 2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNPase). , 2012, The Journal of veterinary medical science.

[52]  W. Brück,et al.  Late motor decline after accomplished remyelination: Impact for progressive multiple sclerosis , 2012, Annals of neurology.

[53]  M. Olah,et al.  Identification of a microglia phenotype supportive of remyelination , 2012, Glia.

[54]  C. Trebst,et al.  Characterisation of microglia during de- and remyelination: Can they create a repair promoting environment? , 2012, Neurobiology of Disease.

[55]  L. Pasquini,et al.  Adult CNP::EGFP transgenic mouse shows pronounced hypomyelination and an increased vulnerability to cuprizone-induced demyelination , 2012, Experimental Neurology.

[56]  R. Armstrong,et al.  Fibroblast growth factor 1 (FGFR1) modulation regulates repair capacity of oligodendrocyte progenitor cells following chronic demyelination , 2012, Neurobiology of Disease.

[57]  M. Day,et al.  Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL/6 mice , 2012, Neuroscience.

[58]  H. Kinney,et al.  Aberrant Upregulation of Astroglial Ceramide Potentiates Oligodendrocyte Injury , 2012, Brain pathology.

[59]  Martin Stangel,et al.  De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected. , 2011, Histology and histopathology.

[60]  F. Zipp,et al.  BLBP-expression in astrocytes during experimental demyelination and in human multiple sclerosis lesions , 2011, Brain, Behavior, and Immunity.

[61]  C. Trebst,et al.  Lipopolysaccharide delays demyelination and promotes oligodendrocyte precursor proliferation in the central nervous system , 2011, Brain, Behavior, and Immunity.

[62]  J. Bol,et al.  Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin‐forming oligodendrocytes during CNS remyelination , 2011, Glia.

[63]  G. Rabinovich,et al.  Galectin-3 drives oligodendrocyte differentiation to control myelin integrity and function , 2011, Cell Death and Differentiation.

[64]  C. Dreyfus,et al.  Levels of BDNF Impact Oligodendrocyte Lineage Cells following a Cuprizone Lesion , 2011, The Journal of Neuroscience.

[65]  K. Guckian,et al.  Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo , 2011, Molecular and Cellular Neuroscience.

[66]  W. Baumgärtner,et al.  Matrix Metalloproteinases and Their Tissue Inhibitors in Cuprizone-Induced Demyelination and Remyelination of Brain White and Gray Matter , 2011, Journal of neuropathology and experimental neurology.

[67]  M. Stangel,et al.  Spatial and Temporal Profiles of Growth Factor Expression during CNS Demyelination Reveal the Dynamics of Repair Priming , 2011, PloS one.

[68]  F. Bosetti,et al.  Time-dependent changes in the brain arachidonic acid cascade during cuprizone-induced demyelination and remyelination. , 2011, Prostaglandins, leukotrienes, and essential fatty acids.

[69]  F. Bosetti,et al.  Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damage. , 2011, Prostaglandins, leukotrienes, and essential fatty acids.

[70]  C. Beyer,et al.  Corticosteroids Impair Remyelination in the Corpus Callosum of Cuprizone‐Treated Mice , 2011, Journal of neuroendocrinology.

[71]  Haiyun Xu,et al.  Recovery of Behavioral Changes and Compromised White Matter in C57BL/6 Mice Exposed to Cuprizone: Effects of Antipsychotic Drugs , 2011, Front. Behav. Neurosci..

[72]  W. Deng,et al.  Zfp488 promotes oligodendrocyte differentiation of neural progenitor cells in adult mice after demyelination , 2011, Scientific reports.

[73]  David M Frim,et al.  Olig1 is expressed in human oligodendrocytes during maturation and regeneration , 2011, Glia.

[74]  S. Ludwin,et al.  Neurobiological effects of sphingosine 1‐phosphate receptor modulation in the cuprizone model , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  M. Grégoire,et al.  Evaluation of [123I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[76]  T. Kilpatrick,et al.  Remyelination Is Altered by Bone Morphogenic Protein Signaling in Demyelinated Lesions , 2011, The Journal of Neuroscience.

[77]  Junhua Xiao,et al.  Gas6 Increases Myelination by Oligodendrocytes and Its Deficiency Delays Recovery following Cuprizone-Induced Demyelination , 2011, PloS one.

[78]  A. Mildner,et al.  IkappaB kinase 2 determines oligodendrocyte loss by non-cell-autonomous activation of NF-kappaB in the central nervous system. , 2011, Brain : a journal of neurology.

[79]  Sheng-Kwei Song,et al.  Reduced Axonopathy and Enhanced Remyelination After Chronic Demyelination in Fibroblast Growth Factor 2 (Fgf2)-Null Mice: Differential Detection With Diffusion Tensor Imaging , 2011, Journal of neuropathology and experimental neurology.

[80]  C. Konradi,et al.  Myelin, copper, and the cuprizone model of schizophrenia. , 2011, Frontiers in bioscience.

[81]  Xiaosong Li,et al.  GAS6 Enhances Repair Following Cuprizone-Induced Demyelination , 2010, PloS one.

[82]  N. Scolding,et al.  Mechanisms of Oxidative Damage in Multiple Sclerosis and a Cell Therapy Approach to Treatment , 2010, Autoimmune diseases.

[83]  H. Hildebrandt,et al.  Remyelination after cuprizone induced demyelination is accelerated in mice deficient in the polysialic acid synthesizing enzyme St8siaIV , 2010, Neuroscience.

[84]  Denis Gris,et al.  The Inflammasome Sensor, NLRP3, Regulates CNS Inflammation and Demyelination via Caspase-1 and Interleukin-18 , 2010, The Journal of Neuroscience.

[85]  S. Barnum,et al.  CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone model. , 2010, Molecular immunology.

[86]  G. Egan,et al.  Influence of methylprednisolone on magnetic resonance and histological measures during cuprizone-induced demyelination , 2010, Neuroscience Letters.

[87]  R. Parenti,et al.  Dynamic expression of Cx47 in mouse brain development and in the cuprizone model of myelin plasticity , 2010, Glia.

[88]  T. Kilpatrick,et al.  Modulation of bone morphogenic protein signalling alters numbers of astrocytes and oligodendroglia in the subventricular zone during cuprizone‐induced demyelination , 2010, Journal of neurochemistry.

[89]  S. Mammi,et al.  Cuprizone neurotoxicity, copper deficiency and neurodegeneration. , 2010, Neurotoxicology.

[90]  J. Ting,et al.  17β-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss , 2010, Neurobiology of Disease.

[91]  O. Elroy-Stein,et al.  A mouse model for eukaryotic translation initiation factor 2B-leucodystrophy reveals abnormal development of brain white matter. , 2010, Brain : a journal of neurology.

[92]  R. Ransohoff,et al.  Myelin Repair Is Accelerated by Inactivating CXCR2 on Nonhematopoietic Cells , 2010, The Journal of Neuroscience.

[93]  Eduardo Soto,et al.  Cuprizone‐induced demyelination in CNP::GFP transgenic mice , 2010, The Journal of comparative neurology.

[94]  C. Trebst,et al.  Beneficial Effects of Minocycline on Cuprizone Induced Cortical Demyelination , 2010, Neurochemical Research.

[95]  R. Klein,et al.  CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination , 2010, Proceedings of the National Academy of Sciences.

[96]  T. Pufe,et al.  ADAM12 is expressed by astrocytes during experimental demyelination , 2010, Brain Research.

[97]  R. Ransohoff,et al.  CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis , 2010, Nature Neuroscience.

[98]  Z. Berente,et al.  Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death. , 2010, Brain : a journal of neurology.

[99]  J. Ting,et al.  Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle , 2010, Journal of neuroscience research.

[100]  R. Browning,et al.  Behavioral and Neurobiological Changes in C57BL/6 Mouse Exposed to Cuprizone: Effects of Antipsychotics , 2010, Front. Behav. Neurosci..

[101]  Richard Reynolds,et al.  HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage , 2009, Nature Neuroscience.

[102]  W. Brück,et al.  In toxic demyelination oligodendroglial cell death occurs early and is FAS independent , 2009, Neurobiology of Disease.

[103]  D. Crawford,et al.  Functional recovery of callosal axons following demyelination: a critical window , 2009, Neuroscience.

[104]  C. Beyer,et al.  Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia , 2009, Brain Research.

[105]  Sjef Copray,et al.  The cuprizone animal model: new insights into an old story , 2009, Acta Neuropathologica.

[106]  C. Konradi,et al.  Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in rats , 2009, Schizophrenia Research.

[107]  Takahira Yamauchi,et al.  Demyelination in the juvenile period, but not in adulthood, leads to long-lasting cognitive impairment and deficient social interaction in mice , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[108]  Martin Stangel,et al.  Regional differences between grey and white matter in cuprizone induced demyelination , 2009, Brain Research.

[109]  W. Paulus,et al.  Cuprizone demyelination of the corpus callosum in mice correlates with altered social interaction and impaired bilateral sensorimotor coordination , 2009, ASN neuro.

[110]  Z. Berente,et al.  17β‐estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice , 2009, Glia.

[111]  C. Moiola,et al.  Partial inhibition of proteasome activity enhances remyelination after cuprizone-induced demyelination , 2009, Experimental Neurology.

[112]  Diego G. Silva,et al.  Demyelination caused by the copper chelator cuprizone halts T cell mediated autoimmune neuroinflammation , 2009, Journal of Neuroimmunology.

[113]  S. Johann,et al.  Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus , 2009, Journal of neuroscience research.

[114]  S. Ludwin,et al.  Statin therapy inhibits remyelination in the central nervous system. , 2009, The American journal of pathology.

[115]  Richard Clough,et al.  Behavioral and neurobiological changes in C57BL/6 mice exposed to cuprizone. , 2009, Behavioral neuroscience.

[116]  W. Brück,et al.  Type I interferon receptor signalling is induced during demyelination while its function for myelin damage and repair is redundant , 2009, Experimental Neurology.

[117]  A. Wanaka,et al.  Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions , 2009, Neurochemistry International.

[118]  A. Chédotal,et al.  Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells , 2009, Annals of neurology.

[119]  J. Stankiewicz,et al.  Role of iron in neurotoxicity: a cause for concern in the elderly? , 2009, Current opinion in clinical nutrition and metabolic care.

[120]  H. Neumann,et al.  Debris clearance by microglia: an essential link between degeneration and regeneration , 2008, Brain : a journal of neurology.

[121]  Patrick Poulet,et al.  Recovery from Chronic Demyelination by Thyroid Hormone Therapy: Myelinogenesis Induction and Assessment by Diffusion Tensor Magnetic Resonance Imaging , 2008, The Journal of Neuroscience.

[122]  R. Hider,et al.  Iron chelation as a potential therapy for neurodegenerative disease. , 2008, Biochemical Society transactions.

[123]  Haiyun Xu,et al.  Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse , 2008, Schizophrenia Research.

[124]  C. Lawless,et al.  Mitochondrial turnover in liver is fast in vivo and is accelerated by dietary restriction: application of a simple dynamic model , 2008, Aging cell.

[125]  C. Brosnan,et al.  Axl−/− mice have delayed recovery and prolonged axonal damage following cuprizone toxicity , 2008, Brain Research.

[126]  K. Takakusaki,et al.  Differential changes in axonal conduction following CNS demyelination in two mouse models , 2008, The European journal of neuroscience.

[127]  J. Ting,et al.  MHC class II exacerbates demyelination in vivo independently of T cells , 2008, Journal of Neuroimmunology.

[128]  T. Abel,et al.  Low sociability is associated with reduced size of the corpus callosum in the BALB/cJ inbred mouse strain , 2008, Brain Research.

[129]  Oded Gonen,et al.  Monitoring demyelination and remyelination by magnetization transfer imaging in the mouse brain at 9.4 T , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.

[130]  R. Franklin,et al.  Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency , 2008, Nature Neuroscience.

[131]  J. Pasquini,et al.  Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination , 2008, Experimental Neurology.

[132]  C. Trebst,et al.  The chemokine receptor CXCR2 is differentially regulated on glial cells in vivo but is not required for successful remyelination after cuprizone‐induced demyelination , 2008, Glia.

[133]  S. Kumar,et al.  Activation of Inflammatory Response by a Combination of Growth Factors in Cuprizone-Induced Demyelinated Brain Leads to Myelin Repair , 2008, Neurochemical Research.

[134]  Jin Young Kim,et al.  Inhibition of p53 Transcriptional Activity: A Potential Target for Future Development of Therapeutic Strategies for Primary Demyelination , 2008, The Journal of Neuroscience.

[135]  K. Irvine,et al.  Remyelination protects axons from demyelination-associated axon degeneration. , 2008, Brain : a journal of neurology.

[136]  Hans Lassmann,et al.  Mitochondrial defects in acute multiple sclerosis lesions , 2008, Brain : a journal of neurology.

[137]  H. Mehmet,et al.  Maturation-dependent sensitivity of oligodendrocyte lineage cells to apoptosis: implications for normal development and disease , 2008, Cell Death and Differentiation.

[138]  P. Carmeliet,et al.  Gas6 Deficiency Increases Oligodendrocyte Loss and Microglial Activation in Response to Cuprizone-Induced Demyelination , 2008, The Journal of Neuroscience.

[139]  G. Egan,et al.  Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair , 2008, Glia.

[140]  Wolfgang Löscher,et al.  Epileptic seizures and hippocampal damage after cuprizone-induced demyelination in C57BL/6 mice , 2008, Experimental Neurology.

[141]  Qing Yang,et al.  MRI identification of the rostral‐caudal pattern of pathology within the corpus callosum in the cuprizone mouse model , 2008, Journal of magnetic resonance imaging : JMRI.

[142]  Blakemore Wf,et al.  Endogenous or exogenous oligodendrocytes for remyelination. , 2008 .

[143]  H. Iocca,et al.  TNF superfamily member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model , 2008, Journal of Neuroimmunology.

[144]  Si-young Song,et al.  Expression of an acyl‐CoA synthetase, lipidosin, in astrocytes of the murine brain and its up‐regulation during remyelination following cuprizone‐induced demyelination , 2007, Journal of neuroscience research.

[145]  R. Kaufman,et al.  Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? , 2007, Antioxidants & redox signaling.

[146]  S. Barnum,et al.  Astrocyte‐specific expression of a soluble form of the murine complement control protein Crry confers demyelination protection in the cuprizone model , 2007, Glia.

[147]  R. Armstrong,et al.  Platelet-Derived Growth Factor Promotes Repair of Chronically Demyelinated White Matter , 2007, Journal of neuropathology and experimental neurology.

[148]  W. Baumgärtner,et al.  Lack of interferon-beta leads to accelerated remyelination in a toxic model of central nervous system demyelination , 2007, Acta Neuropathologica.

[149]  M. Carson,et al.  Lymphotoxin β Receptor (LtβR): Dual Roles in Demyelination and Remyelination and Successful Therapeutic Intervention Using LtβR–Ig Protein , 2007, The Journal of Neuroscience.

[150]  L. Vallières,et al.  Identification of genes preferentially expressed by microglia and upregulated during cuprizone‐induced inflammation , 2007, Glia.

[151]  A. Casini,et al.  Unravelling the chemical nature of copper cuprizone. , 2007, Dalton transactions.

[152]  T. Owens,et al.  Microglial recruitment, activation, and proliferation in response to primary demyelination. , 2007, The American journal of pathology.

[153]  T. Ueki,et al.  Restoration of FcRγ/Fyn signaling repairs central nervous system demyelination , 2007, Neuroscience Research.

[154]  E. Vilella,et al.  Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelination. , 2007, Toxicology letters.

[155]  T. Yagi,et al.  Restoration of FcRgamma/Fyn signaling repairs central nervous system demyelination. , 2007, Journal of neuroscience research.

[156]  M. Carson,et al.  Lymphotoxin beta receptor (Lt betaR): dual roles in demyelination and remyelination and successful therapeutic intervention using Lt betaR-Ig protein. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[157]  S. Kumar,et al.  Combination of Growth Factors Enhances Remyelination in a Cuprizone-induced Demyelination Mouse Model , 2007, Neurochemical Research.

[158]  L. Pasquini,et al.  The Neurotoxic Effect of Cuprizone on Oligodendrocytes Depends on the Presence of Pro-inflammatory Cytokines Secreted by Microglia , 2007, Neurochemical Research.

[159]  D. Willenborg,et al.  Neuronal Nitric Oxide Synthase Plays a Key Role in CNS Demyelination , 2006, The Journal of Neuroscience.

[160]  D. Liebetanz,et al.  Effects of commissural de- and remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis , 2006, Experimental Neurology.

[161]  Y. J. Kang.  Metallothionein Redox Cycle and Function , 2006, Experimental biology and medicine.

[162]  G. Almazan,et al.  Iron contributes to dopamine‐induced toxicity in oligodendrocyte progenitors , 2006, Neuropathology and applied neurobiology.

[163]  A. Schousboe,et al.  The glutamate/GABA‐glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer , 2006, Journal of neurochemistry.

[164]  W. F. Blakemore,et al.  Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice , 2006, Journal of Neuroimmunology.

[165]  R. Kothary,et al.  Dominant‐negative β1 integrin mice have region‐specific myelin defects accompanied by alterations in MAPK activity , 2006, Glia.

[166]  T. Guilarte,et al.  Imaging the peripheral benzodiazepine receptor response in central nervous system demyelination and remyelination. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[167]  T. Kilpatrick,et al.  Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[168]  D. Ron,et al.  Interferon-γ inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress , 2006 .

[169]  D. Willenborg,et al.  Deleterious role of IFNgamma in a toxic model of central nervous system demyelination. , 2006, The American journal of pathology.

[170]  P. Paez,et al.  Remyelination after cuprizone-induced demyelination in the rat is stimulated by apotransferrin , 2006, Experimental Neurology.

[171]  M. Carson,et al.  Upregulation of the stress‐associated gene p8 in mouse models of demyelination and in multiple sclerosis tissues , 2006, Glia.

[172]  R. Armstrong,et al.  Endogenous Cell Repair of Chronic Demyelination , 2006, Journal of neuropathology and experimental neurology.

[173]  Hsiao-Fang Liang,et al.  Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum , 2006, Magnetic resonance in medicine.

[174]  Chao Zhao,et al.  Myelin Impairs CNS Remyelination by Inhibiting Oligodendrocyte Precursor Cell Differentiation , 2006, The Journal of Neuroscience.

[175]  W. Cammer,et al.  Expression of carbonic anhydrase II mRNA and protein in oligodendrocytes during toxic demyelination in the young adult mouse , 1996, Neurochemical Research.

[176]  D. Ron,et al.  Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. , 2006, Brain : a journal of neurology.

[177]  H. Boddeke,et al.  p75NTR independent oligodendrocyte death in cuprizone‐induced demyelination in C57BL/6 mice , 2005, Neuropathology and applied neurobiology.

[178]  John Calvin Reed,et al.  Endoplasmic reticulum stress: cell life and death decisions. , 2005, The Journal of clinical investigation.

[179]  Jens Frahm,et al.  Multicontrast MRI of remyelination in the central nervous system , 2005, NMR in biomedicine.

[180]  Petti T. Pang,et al.  The yin and yang of neurotrophin action , 2005, Nature Reviews Neuroscience.

[181]  W. Wittkowski,et al.  Copper and zinc dismetabolism in the mouse brain upon chronic cuprizone treatment , 2005, Cellular and Molecular Life Sciences CMLS.

[182]  R. Armstrong,et al.  PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination , 2005, Neurobiology of Disease.

[183]  Jun Yoshino,et al.  Demyelination increases radial diffusivity in corpus callosum of mouse brain , 2005, NeuroImage.

[184]  S. Komoly.  Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected]. , 2005, Ideggyogyaszati szemle.

[185]  M. Subramanian,et al.  Effect of cuprizone feeding on hepatic superoxide dismutase and cytochrome oxidase activities in mice , 1982, Experientia.

[186]  H. Arnett,et al.  Astroglial‐derived lymphotoxin‐α exacerbates inflammation and demyelination, but not remyelination , 2005, Glia.

[187]  E. Mandelkow,et al.  Hyperphosphorylation and Aggregation of Tau in Experimental Autoimmune Encephalomyelitis* , 2004, Journal of Biological Chemistry.

[188]  D. Rowitch,et al.  bHLH Transcription Factor Olig1 Is Required to Repair Demyelinated Lesions in the CNS , 2004, Science.

[189]  Trevor J Kilpatrick,et al.  Expression of the low‐affinity neurotrophin receptor, p75NTR, is upregulated by oligodendroglial progenitors adjacent to the subventricular zone in response to demyelination , 2004, Glia.

[190]  Olivier Yu,et al.  Remyelination assessment by MRI texture analysis in a cuprizone mouse model. , 2004, Magnetic resonance imaging.

[191]  U. Suter,et al.  Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. , 2004, Brain : a journal of neurology.

[192]  B. Popko,et al.  Oligodendrocytes assist in the maintenance of sodium channel clusters independent of the myelin sheath. , 2004, Neuron glia biology.

[193]  Á. Hermida-Ameijeiras,et al.  Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions , 2004, Neurochemistry International.

[194]  S. Levison,et al.  Pro‐regenerative properties of cytokine‐activated astrocytes , 2004, Journal of neurochemistry.

[195]  T. Guilarte,et al.  Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization. , 2004, Brain : a journal of neurology.

[196]  J. Goldman,et al.  Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. , 2004, The American journal of pathology.

[197]  U. Boschert,et al.  Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro , 2004, Molecular and Cellular Neuroscience.

[198]  G. Rotilio,et al.  Mitochondrial Dysfunction in Neurodegenerative Diseases Associated with Copper Imbalance , 2004, Neurochemical Research.

[199]  W. Richardson,et al.  Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination , 2004, Molecular and Cellular Neuroscience.

[200]  Santa Jeremy Ono,et al.  A CIITA‐independent pathway that promotes expression of endogenous rather than exogenous peptides in immune‐privileged sites , 2004, European journal of immunology.

[201]  E. M. Carey,et al.  Biochemical changes in cuprizone-induced spongiform encephalopathy , 1983, Neurochemical Research.

[202]  S. Ludwin,et al.  An immunohistochemical study of myelin proteins during remyelination in the central nervous system , 2004, Acta Neuropathologica.

[203]  J. Ting,et al.  Functional Genomic Analysis of Remyelination Reveals Importance of Inflammation in Oligodendrocyte Regeneration , 2003, The Journal of Neuroscience.

[204]  Ueli Suter,et al.  Quantifying the Early Stages of Remyelination Following Cuprizone‐induced Demyelination , 2003, Brain pathology.

[205]  P. Paez,et al.  Inhibition of the Proteasome by Lactacystin Enhances Oligodendroglial Cell Differentiation , 2003, The Journal of Neuroscience.

[206]  G. Levi,et al.  Differential Lipid Peroxidation, Mn Superoxide, and bcl‐2 Expression Contribute to the Maturation‐Dependent Vulnerability of Oligodendrocytes to Oxidative Stress , 2003, Journal of neuropathology and experimental neurology.

[207]  M. Goldberg,et al.  Oligodendrocytes and Ischemic Brain Injury , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[208]  K. Jellinger,et al.  Preferential Loss of Myelin‐Associated Glycoprotein Reflects Hypoxia‐Like White Matter Damage in Stroke and Inflammatory Brain Diseases , 2003, Journal of neuropathology and experimental neurology.

[209]  B. Juurlink,et al.  Differential vulnerability of oligodendrocytes and astrocytes to hypoxic–ischemic stresses , 2003 .

[210]  T. Wakabayashi.  Megamitochondria formation ‐ physiology and pathology , 2002, Journal of cellular and molecular medicine.

[211]  R. Armstrong,et al.  Absence of Fibroblast Growth Factor 2 Promotes Oligodendroglial Repopulation of Demyelinated White Matter , 2002, The Journal of Neuroscience.

[212]  G. Matsushima,et al.  Peripheral macrophage recruitment in cuprizone-induced CNS demyelination despite an intact blood–brain barrier , 2002, Journal of Neuroimmunology.

[213]  D. Sammond,et al.  Alterations in metabolism and gene expression in brain regions during cuprizone‐induced demyelination and remyelination , 2002, Journal of neurochemistry.

[214]  P. Sanberg,et al.  Neuroscience and Biobehavioral Reviews , 2002, Physiology & Behavior.

[215]  J. Ting,et al.  The Protective Role of Nitric Oxide in a Neurotoxicant- Induced Demyelinating Model1 , 2002, The Journal of Immunology.

[216]  J. Ting,et al.  TNFα promotes proliferation of oligodendrocyte progenitors and remyelination , 2001, Nature Neuroscience.

[217]  M. Ruberg,et al.  Noradrenaline provides long‐term protection to dopaminergic neurons by reducing oxidative stress , 2001, Journal of neurochemistry.

[218]  D. Chaplin,et al.  Interleukin-1β Promotes Repair of the CNS , 2001, The Journal of Neuroscience.

[219]  D. Cook,et al.  Absence of Macrophage-Inflammatory Protein-1α Delays Central Nervous System Demyelination in the Presence of an Intact Blood-Brain Barrier1 , 2001, The Journal of Immunology.

[220]  L. Horrocks,et al.  Book Review: Plasmalogens: Workhorse Lipids of Membranes in Normal and Injured Neurons and Glia , 2001 .

[221]  D. Sammond,et al.  Cerebroside synthesis as a measure of the rate of remyelination following cuprizone‐induced demyelination in brain , 2001, Journal of neurochemistry.

[222]  N. Baumann,et al.  Biology of oligodendrocyte and myelin in the mammalian central nervous system. , 2001, Physiological reviews.

[223]  K Suzuki,et al.  Episodic demyelination and subsequent remyelination within the murine central nervous system: changes in axonal calibre , 2001, Neuropathology and applied neurobiology.

[224]  P. Morell,et al.  The Neurotoxicant, Cuprizone, as a Model to Study Demyelination and Remyelination in the Central Nervous System , 2001, Brain pathology.

[225]  K Suzuki,et al.  TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. , 2001, Nature neuroscience.

[226]  D. Chaplin,et al.  Interleukin-1beta promotes repair of the CNS. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[227]  L. Horrocks,et al.  Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia. , 2001, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[228]  P. Ye,et al.  Interferon-γ Protects against Cuprizone-Induced Demyelination , 2000, Molecular and Cellular Neuroscience.

[229]  M. Taniike,et al.  Mature oligodendrocyte apoptosis precedes IGF‐1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination , 2000, Journal of neuroscience research.

[230]  P. Ye,et al.  Insulin-Like Growth Factor-1 Inhibits Mature Oligodendrocyte Apoptosis during Primary Demyelination , 2000, The Journal of Neuroscience.

[231]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[232]  P. Ye,et al.  Interferon-gamma protects against cuprizone-induced demyelination. , 2000, Molecular and cellular neurosciences.

[233]  W. Cammer.  The neurotoxicant, cuprizone, retards the differentiation of oligodendrocytes in vitro , 1999, Journal of the Neurological Sciences.

[234]  K. Suzuki,et al.  Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice , 1998, Journal of Neuroimmunology.

[235]  A. Lees,et al.  Conjugates of Catecholamines with Cysteine and GSH in Parkinson's Disease: Possible Mechanisms of Formation Involving Reactive Oxygen Species , 1998, Journal of neurochemistry.

[236]  P. Morell,et al.  Gene Expression in Brain during Cuprizone-Induced Demyelination and Remyelination , 1998, Molecular and Cellular Neuroscience.

[237]  L. Hertz,et al.  Peroxide‐scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress , 1998, Glia.

[238]  A. Consiglio,et al.  Tumor necrosis factor α and its receptors in relapsing-remitting multiple sclerosis , 1997, Journal of the Neurological Sciences.

[239]  H. Zhang,et al.  Rapid upregulation of the Pi isoform of glutathione-S-transferase in mouse brains after withdrawal of the neurotoxicant, cuprizone. , 1997, Molecular and chemical neuropathology.

[240]  B. Trapp,et al.  Differentiation and Death of Premyelinating Oligodendrocytes in Developing Rodent Brain , 1997, The Journal of cell biology.

[241]  H. Lassmann,et al.  TNF-α receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview , 1997, Journal of Neuroimmunology.

[242]  A. Consiglio,et al.  Tumor necrosis factor alpha and its receptors in relapsing-remitting multiple sclerosis. , 1997, Journal of the neurological sciences.

[243]  H. Zhang,et al.  Atypical localization of the oligodendrocytic isoform (PI) of glutathione‐S‐transferase in astrocytes during cuprizone intoxication , 1993, Journal of neuroscience research.

[244]  H. Webster,et al.  Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[245]  M. Zoratti,et al.  A characterization of cuprizone-induced giant mouse liver mitochondria , 1990, Journal of bioenergetics and biomembranes.

[246]  S. Love,et al.  Cuprizone neurotoxicity in the rat: Morphologic observations , 1988, Journal of the Neurological Sciences.

[247]  S. Ludwin,et al.  Blood-brain barrier permeability during Cuprizone-induced demyelination Implications for the pathogenesis of immune-mediated demyelinating diseases , 1987, Journal of the Neurological Sciences.

[248]  D. Gospodarowicz,et al.  Fibroblast growth factor , 1986, Molecular and Cellular Endocrinology.

[249]  Russanov Em,et al.  Differences in the in vivo effects of cuprizone on superoxide dismutase activity in rat liver cytosol and mitochondrial intermembrane space. , 1985 .

[250]  E. Russanov,et al.  Differences in the in vivo effects of cuprizone on superoxide dismutase activity in rat liver cytosol and mitochondrial intermembrane space. , 1985, Acta physiologica et pharmacologica Bulgarica.

[251]  Blakemore Wf.  The response of oligodendrocytes to chemical injury. , 1984 .

[252]  W. Blakemore.  The response of oligodendrocytes to chemical injury. , 1984, Acta neurologica Scandinavica. Supplementum.

[253]  K. Famulski,et al.  Changes in the mitochondrial surface potential during cuprizone-induced formation of megamitochondria. , 1982, European Journal of Cell Biology.

[254]  T. Flatmark,et al.  Induction of megamitochondria by cuprizone(biscyclohexanone oxaldihydrazone). Evidence for an inhibition of the mitochondrial division process. , 1980, European journal of cell biology.

[255]  Ludwin Sk.  Chronic demyelination inhibits remyelination in the central nervous system. An analysis of contributing factors. , 1980 .

[256]  E. Russanov,et al.  Effect of cuprizone on copper exchange and superoxide dismutase activity in rat liver. , 1980, General pharmacology.

[257]  S. Ludwin.  Chronic demyelination inhibits remyelination in the central nervous system. An analysis of contributing factors. , 1980, Laboratory investigation; a journal of technical methods and pathology.

[258]  Ludwin Sk.  Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. , 1978 .

[259]  H. Kishimoto,et al.  MECHANISM OF THE FORMATION OF MEGAMITOCHONDRIA BY COPPER‐CHELATING AGENTS V. FURTHER STUDIES ON ISOLATED MEGAMITOCHONDRIA , 1978, Acta pathologica japonica.

[260]  H. Kishimoto,et al.  MECHANISM OF THE FORMATION OF MEGAMITOCHONDRIA BY COPPER‐CHELATING AGENTS IV. ROLE OF FUSION PHENOMENON IN THE CUPRIZONE‐INDUCED MEGAMITOCHONDRIAL FORMATION , 1978, Acta pathologica japonica.

[261]  S. Ludwin.  Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. , 1978, Laboratory investigation; a journal of technical methods and pathology.

[262]  J. Rafael,et al.  Biochemical properties of liver megamitochondria induced by chloramphenicol or cuprizone. , 1977, Experimental cell research.

[263]  H. Kishimoto,et al.  Cuprizone-induced megamitochondrial formation and membrane fusion. , 1977, Journal of electron microscopy.

[264]  R. Kimberlin,et al.  Profiles of brain glycosidase activity in cuprizone-fed Syrian hamsters and in scrapie-affected mice, rats, Chinese hamsters and Syrian hamsters. , 1976, Journal of comparative pathology.

[265]  T. Ozawa,et al.  MECHANISM OF THE FORMATION OF MEGAMITOCHONDRIA INDUCED BY COPPER‐CHELATING AGENTS , 1975, Acta pathologica japonica.

[266]  C. Kurono,et al.  Mechanism of the formation of megamitochondria induced by copper-chelating agents. II. Isolation and some properties of megamitochondria from the cuprizone-treated mouse liver. , 1975, Acta pathologica japonica.

[267]  C. Hoppel,et al.  The failure of supplemental dietary copper to prevent cuprizone-induced alterations in mouse hepatocytes. , 1975, Beitrage zur Pathologie.

[268]  G Venturini,et al.  ENZYMIC ACTIVITIES AND SODIUM, POTASSIUM AND COPPER CONCENTRATIONS IN MOUSE BRAIN AND LIVER AFTER CUPRIZONE TREATMENT IN VIVO , 1973, Journal of neurochemistry.

[269]  B. Sansom,et al.  Permeability of blood vessels in mice affected with scrapie or fed with cuprizone. , 1973, Journal of comparative pathology.

[270]  W. Blakemore.  Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. , 1973, Journal of the neurological sciences.

[271]  J. Howell,et al.  Variation in the response of mice to cuprizone. , 1973, Research in veterinary science.

[272]  C. Hoppel,et al.  DIVISION OF GIANT MITOCHONDRIA DURING RECOVERY FROM CUPRIZONE INTOXICATION , 1973, The Journal of cell biology.

[273]  W. Blakemore.  Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice , 1972, Journal of neurocytology.

[274]  W. Carlton,et al.  Cuprizone toxicosis in mice--attempts to antidote the toxicity. , 1972, Toxicology and applied pharmacology.

[275]  W. Carlton,et al.  Histopathologic and enzyme histochemical observations of the cuprizone-induced brain edema. , 1971, Experimental and molecular pathology.

[276]  I. Pattison,et al.  Clinical and histological observations on cuprizone toxicity and scrapie in mice. , 1971, Research in veterinary science.

[277]  W. Carlton,et al.  Ultrastructural changes of cuprizone encephalopathy in mice. , 1971, Toxicology and applied pharmacology.

[278]  W. Carlton,et al.  Aqueductal stenosis as the cause of hydrocephalus in mice fed the substituted hydrazine, cuprizone. , 1970, Experimental and molecular pathology.

[279]  W. Carlton,et al.  Spongiform encephalopathy induced in rats and guinea pigs by cuprizone. , 1969, Experimental and molecular pathology.

[280]  Kinuko Suzuki.  Giant Hepatic Mitochondria: Production in Mice Fed with Cuprizone , 1969, Science.

[281]  W. Carlton,et al.  Studies on the induction of hydrocephalus and spongy degeneration by cuprizone feeding and attempts to antidote the toxicity. , 1967, Life sciences.

[282]  W. Carlton,et al.  Response of mice to the chelating agents sodium diethyldithiocarbamate, alpha-benzoinoxime, and biscyclohexanone oxaldihydrazone. , 1966, Toxicology and applied pharmacology.

[283]  G. D. De Beer.  New insight into an old story , 1966 .

[284]  P. Kinell,et al.  A New Colour Reaction on Copper and Certain Carbonyl Compounds. , 1950 .